Forum: Besides TCM, study other traditional methods for healthcare
Patients often tell me they get relief, from minor indispositions to medical problems, using traditional methods after they tried the normal Western medical methodology which seemed to have failed them.
The Ministry of Health already has a framework of standards for using traditional Chinese medicine (TCM) as part of public healthcare. While it is actively researching the efficacy of other TCM methods in treating afflictions, we should also study traditional modes of therapy adopted by other countries.
India is a good example.
The practice of Ayurvedic therapy, involving a holistic process of herbal medicine, dietary rebalancing, yoga, massage and purification programmes, has long kept India, with its population beyond a billion people, hale, hearty and fecund.
Shouldn't we study and research these in detail too and then add them to our models of treatment?
In our multiracial society, we should be able to accept and incorporate more than one set of traditional medical methodologies into the national healthcare system.
Dr Yik Keng Yeong

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Straits Times
3 hours ago
- Straits Times
Artificial sweetener consumption linked to less effective cancer treatment
Sign up now: Get ST's newsletters delivered to your inbox High consumption of sucralose was linked with lower effectiveness of immunotherapies across a range of cancer types, stages and treatment methods. In patients with melanoma or non-small cell lung cancer, consuming high levels of the artificial sweetener sucralose contributes to diminished responses to immunotherapy and poorer survival, researchers reported in Cancer Discovery. When the researchers had 132 patients with advanced melanoma or non-small cell lung cancer answer detailed diet history questionnaires, they found that high consumption of sucralose was linked with lower effectiveness of immunotherapies across a range of cancer types, stages and treatment methods. In experiments with mice, the researchers found that sucralose shifts the composition of microbes in the intestines, increasing bacterial species that degrade arginine, an amino acid that is essential for key immune cells called T cells. 'When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly,' study leader Abby Overacre of the University of Pittsburgh said in a statement. 'As a result, immunotherapy wasn't as effective in mice that were fed sucralose.' Laying the groundwork for a solution to the problem, the same researchers also found in the mice that supplements that boosted levels of arginine mitigated the negative effects of sucralose on immunotherapy, an approach they now hope to test in humans. 'It's easy to say, 'Stop drinking diet soda,' but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic,' Overacre said. 'That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy.' REUTERS

Straits Times
15 hours ago
- Straits Times
Gaza mother worries time running out for evacuation of malnourished daughter
Sign up now: Get ST's newsletters delivered to your inbox GAZA CITY - Stroking the hair of her emaciated daughter on a hospital bed in Gaza City, Nasma Ayad fears time is running out for a medical evacuation of the malnourished eight-year-old to avoid the fate of her sister, who died last month. "I feel I'm slowly losing my daughter, day after day - everything she's suffering from is multiplying," Ayad said. With few medical supplies and limited food, treating malnourished Palestinian children with complicated conditions in war-shattered Gaza has become increasingly difficult, according to medical staff and humanitarian agencies. Jana received treatment for malnutrition last year at an International Medical Corps clinic in the central town of Deir al-Balah after showing signs of weakness and delayed growth. Though she improved, the frequent interruption of healthcare services and increasing scarcity of food - as Israeli forces who control all access to Gaza have kept up their offensive against Hamas militants - led to a relapse, Ayad said. She weighs just 11 kilograms (24 pounds) and has trouble seeing, speaking or standing up. "She started having an edema, which is fluid retention that makes the limbs and the body swell and store water because of the lack of protein and food," said Suzan Marouf, a therapeutic nutritionist at Patient Friend's Benevolent Society Hospital. Top stories Swipe. Select. Stay informed. Tech Reporting suspected advanced cyber attacks will provide a defence framework: Shanmugam Business Singapore's US tariff rate stays at 10%, but the Republic is not out of the woods yet World As China-US tariff truce talks drag on, what are prospects for a 'big deal' for Trump? Singapore Thundery showers expected on most days in first half of August Singapore SPH Media awards three journalism scholarships to budding newsroom talent Singapore Synapxe chief executive, MND deputy secretary to become new perm secs on Sept 1 Singapore 5 women face capital charges after they were allegedly found with nearly 27kg of cocaine in S'pore Business Sumo Salad had valid insurance coverage for work injury claims: MOM Jana's sister, Joury, died on July 20. The child had kidney problems exacerbated by malnutrition, her mother said. Gaza's spiralling humanitarian crisis prompted the main world hunger monitoring body on Tuesday to assess that a worst-case scenario of famine is unfolding, and that immediate action is needed to avoid widespread death. Images of emaciated Palestinian children have shocked many around the world. Gazan health authorities have reported more and more people dying from hunger-related causes. The total now stands at 156, among them 90 children, most of whom died in the past few weeks. Ayad had hoped both her girls could be evacuated to safety to receive treatment outside the Gaza Strip. Health officials had added them to a list of patients who were in need of evacuation last September. But the evacuations never transpired. Though it was too late for Joury, her mother still holds out some hope for Jana. "I am calling for the urgent referral of Jana as soon as possible to be treated outside the country," she said. With the international furore over Gaza's ordeal growing, Israel announced steps over the weekend to ease aid access. But the U.N. World Food Programme said on Tuesday it was still not getting the permissions needed to deliver sufficient aid. Israel and the U.S. accuse Hamas of stealing aid - which the Islamist group denies - and the U.N. of failing to prevent this. The United Nations says it has seen no evidence of Hamas diverting much aid. Hamas accuses Israel of causing starvation and using aid as a weapon, which the Israeli government denies. REUTERS

Straits Times
17 hours ago
- Straits Times
US plans Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
Sign up now: Get ST's newsletters delivered to your inbox GLP-1 drugs have gained popularity for their ability to reduce body weight by suppressing appetite and slowing digestion. WASHINGTON - The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Aug 1, citing documents from the Centers for Medicare and Medicaid Services. GLP-1 drugs, originally developed for type 2 diabetes, have gained popularity for their ability to reduce body weight by suppressing appetite and slowing digestion. But their high cost – typically between US$5,000 (S$6,490) and US$7,000 per year – has raised concerns about long-term affordability. The proposed plan would permit state Medicaid programs and Medicare Part D insurance plans to voluntarily cover GLP-1 drugs, including those from market leaders Novo Nordisk and Eli Lilly, the report said. Lilly and Novo are leaders in the weight-loss drug market, which some analysts expect could bring in more than US$150 billion in revenues by the next decade. Lilly's shares were up nearly 2 per cent in premarket trading. The initiative is slated to begin in April 2026 for Medicaid and January 2027 for Medicare. If it clears the way, it would mark a shift in federal policy after the administration said earlier this year that the programs would not cover weight loss drugs. A proposal under the Biden administration had also aimed to expand access to the medications. The Centres for Medicare & Medicaid Services, Lilly and Novo did not immediately respond to a Reuters request for comment. REUTERS